drug manufacturing

BOSTON — September 28, 2026 CervoMed Inc. announced pharmacokinetic, regulatory and manufacturing advances for neflamapimod, including a new 50...

REDWOOD CITY, Calif. — September 28, 2026 Codexis, Inc. announced an agreement with a pioneering siRNA drug innovator to...

AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...

Mequon, Wisconsin, August 17, 2026 Vector Science and Therapeutics Corp. has entered into an amended and restated exclusive license...

IRVINE, Calif., August 12, 2026 Cycle Pharmaceuticals announced a commercial manufacturing agreement with Forma Life Sciences to establish a...

Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...

Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...

PLAINSBORO, New Jersey, USA / BAGSVÆRD, Denmark, July 11, 2026 Novo Nordisk has announced positive long-term Phase 3 results...

SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...

VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...